Chorus Pharma, a division of Eli Lilly and Company, was launched to transform the traditional drug development process through a lean approach to generating clinical proof of concept (PoC) data, with a more flexible and virtually-outsourced model. The objective was clear: achieve the maximum change on the probability of technical success through PoC by adding value as quickly and cost-effectively as possible.
Chorus, now an important part of Eli Lilly’s fully-integrated pharmaceutical network strategy, operates much like a lean biotechnology company within the walls of a larger biopharmaceutical company. It has helped to reduce both the time and cost of drug development for PoC, resulting in substantial productivity improvements over traditional pharmaceutical development.
The group’s founders, who were very experienced in sourcing clinical trials, created a series of spreadsheet-based budgeting tools, which Chorus used to determine the value and cost of its services. As Chorus began to grow and handle more studies for Eli Lilly, as well as external clients, it looked for a more robust tool that would enable incorporating more granular data, with the goal of reducing budget variances. It also wanted a more flexible tool that would be suited for different types of trials and could relieve the internal team of tedious budget tool maintenance.
Chorus Pharma selected Oracle Health Sciences ClearTrial Plan and Source Standard Edition Cloud Service and is using it to manage approximately 15 trials each year. With the new system, Chorus has replaced maintenance-intensive, spreadsheet-based budget tools with more granular, automated models, reducing budget variance to 5% to 10%, when it previously had been up to 20%. The group also gained flexibility to bid a broader array of trials, delivering additional value to internal and external clients.
“We wanted a system that eliminated tedious spreadsheet maintenance and could provide the level of budget granularity we required,” said Ken Olovich, chief procurement and financial officer, Chorus Pharma. “Other commercial tools simply could not deliver the level of detail that ClearTrial could. And, the system was easy to use-and navigate, which helped to jumpstart user adoption and improve productivity. The pages are intuitive. All of the information is grouped logically on various tabs.”
The implementation was rapid and seamless. Chorus Pharma had the system up and running in a month.